Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Liabilities and Shareholders Equity: 2009-2024

Historic Liabilities and Shareholders Equity for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to $589.3 million.

  • Cross Country Healthcare's Liabilities and Shareholders Equity fell 990.79% to $538.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year decrease of 1076.26%. This contributed to the annual value of $589.3 million for FY2024, which is 1348.08% down from last year.
  • According to the latest figures from FY2024, Cross Country Healthcare's Liabilities and Shareholders Equity is $589.3 million, which was down 1348.08% from $681.1 million recorded in FY2023.
  • In the past 5 years, Cross Country Healthcare's Liabilities and Shareholders Equity ranged from a high of $949.6 million in FY2022 and a low of $357.0 million during FY2020
  • Its 5-year average for Liabilities and Shareholders Equity is $661.9 million, with a median of $681.1 million in 2023.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first soared by 10528.42% in 2021, then plummeted by 2827.78% in 2023.
  • Cross Country Healthcare's Liabilities and Shareholders Equity (Annual) stood at $357.0 million in 2020, then surged by 105.28% to $732.8 million in 2021, then grew by 29.58% to $949.6 million in 2022, then fell by 28.28% to $681.1 million in 2023, then fell by 13.48% to $589.3 million in 2024.
  • Its Liabilities and Shareholders Equity was $589.3 million in FY2024, compared to $681.1 million in FY2023 and $949.6 million in FY2022.